FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sabrina Pacor

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Marta Vadori; Francesca Vita; Sonia Zorzet; Moreno Cocchietto; Sabrina Pacor; Gianni Sava
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice.
L Vaccari; Sabrina Pacor; G Birarda; L Businaro; G Grenci
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): toward a powerful label-free cell-based assay.
Francesca Morgera; Sabrina Pacor; Luisa Creatti; Nikolinka Antcheva; Lisa Vaccari; Alessandro Tossi
Effects on antigen-presenting cells of short-term interaction with the human host defence peptide β-defensin 2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sabrina Pacor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marta Vadori; Francesca Vita; Sonia Zorzet; Moreno Cocchietto; Sabrina Pacor; Gianni Sava
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice.
Journal of inorganic biochemistry 2013;118():21-7.
2012: L Vaccari; Sabrina Pacor; G Birarda; L Businaro; G Grenci
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): toward a powerful label-free cell-based assay.
Analytical chemistry 2012;84(11):4768-75.
2011: Francesca Morgera; Sabrina Pacor; Luisa Creatti; Nikolinka Antcheva; Lisa Vaccari; Alessandro Tossi
Effects on antigen-presenting cells of short-term interaction with the human host defence peptide β-defensin 2.
The Biochemical journal 2011;436(3):537-46.
2011: Monica Benincasa; Sabrina Pacor; Wei Wu; Maurizio Prato; Alberto Bianco; Renato Gennaro
Antifungal activity of amphotericin B conjugated to carbon nanotubes.
ACS nano 2011;5(1):199-208.
2009: Linda Tomasinsig; Francesca Morgera; Nikolinka Antcheva; Sabrina Pacor; Barbara Skerlavaj; Margherita Zanetti; Alessandro Tossi
Structure dependence of biological activities for primate cathelicidins.
Journal of peptide science : an official publication of the European Peptide Society 2009;15(9):576-82.
2009: Monica Benincasa; Sabrina Pacor; Renato Gennaro; Marco Scocchi
Rapid and reliable detection of antimicrobial peptide penetration into gram-negative bacteria based on fluorescence quenching.
Antimicrobial agents and chemotherapy 2009;53(8):3501-4.
2009: Nikolinka Antcheva; Francesca Morgera; Luisa Creatti; Lisa Vaccari; Ulrike Pag; Sabrina Pacor; Yechiel Shai; Hans-Georg Sahl; Alessandro Tossi
Artificial beta-defensin based on a minimal defensin template.
The Biochemical journal 2009;421(3):435-47.
2009: Francesca Morgera; Lisa Vaccari; Nikolinka Antcheva; Denis Scaini; Sabrina Pacor; Alessandro Tossi
Primate cathelicidin orthologues display different structures and membrane interactions.
The Biochemical journal 2009;417(3):727-35.
2008: Nevenka Medic; Francesca Vita; Rita Abbate; Maria Rosa Soranzo; Sabrina Pacor; Elsa Fabbretti; Violetta Borelli; Giuliano Zabucchi
Mast cell activation by myelin through scavenger receptor.
Journal of neuroimmunology 2008;200(1-2):27-40.
2008: Eleonora Marsich; Pamela Mozetic; Fulvia Ortolani; Magali Contin; Maurizio Marchini; Amedeo Vetere; Sabrina Pacor; Sabrina Semeraro; Franco Vittur; Sergio Paoletti
Galectin-1 in cartilage: expression, influence on chondrocyte growth and interaction with ECM components.
Matrix biology : journal of the International Society for Matrix Biology 2008;27(6):513-25.
2008: Francesca Morgera; Nikolinka Antcheva; Sabrina Pacor; Luca Quaroni; Federico Berti; Lisa Vaccari; Alessandro Tossi
Structuring and interactions of human beta-defensins 2 and 3 with model membranes.
Journal of peptide science : an official publication of the European Peptide Society 2008;14(4):518-23.
2007: Maura Mattiuzzo; Antonella Bandiera; Renato Gennaro; Monica Benincasa; Sabrina Pacor; Nikolinka Antcheva; Marco Scocchi
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides.
Molecular microbiology 2007;66(1):151-63.
2006: Elena Podda; Monica Benincasa; Sabrina Pacor; Fulvio Micali; Maura Mattiuzzo; Renato Gennaro; Marco Scocchi
Dual mode of action of Bac7, a proline-rich antibacterial peptide.
Biochimica et biophysica acta 2006;1760(11):1732-40.
2006: Monica Benincasa; Marco Scocchi; Sabrina Pacor; Alessandro Tossi; Donatella Nobili; Giancarlo Basaglia; Marina Busetti; Renato Gennaro
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts.
The Journal of antimicrobial chemotherapy 2006;58(5):950-9.
2006: Igor Zelezetsky; Alessandra Pontillo; Luca Puzzi; Nikolinka Antcheva; Ludovica Segat; Sabrina Pacor; Sergio Crovella; Alessandro Tossi
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.
The Journal of biological chemistry 2006;281(29):19861-71.
2005: Igor Zelezetsky; Sabrina Pacor; Ulrike Pag; niv papo; Yechiel Shai; Hans-Georg Sahl; Alessandro Tossi
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity.
The Biochemical journal 2005;390(Pt 1):177-88.
2005: Sergio Crovella; Nikolinka Antcheva; Igor Zelezetsky; Michele Boniotto; Sabrina Pacor; Maria Vittoria Verga Falzacappa; Alessandro Tossi
Primate beta-defensins--structure, function and evolution.
Current protein & peptide science 2005;6(1):7-21.
2004: Marina Bacac; Marta Vadori; Gianni Sava; Sabrina Pacor
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells.
Cancer immunology, immunotherapy : CII 2004;53(12):1101-10.
2004: Sabrina Pacor; Sonia Zorzet; Moreno Cocchietto; Marina Bacac; Marta Vadori; Claudia Turrin; Barbara Gava; Anna Castellarin; Gianni Sava
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
The Journal of pharmacology and experimental therapeutics 2004;310(2):737-44.
2004: Nikolinka Antcheva; Michele Boniotto; Igor Zelezetsky; Sabrina Pacor; Maria Vittoria Verga Falzacappa; Sergio Crovella; Alessandro Tossi
Effects of positively selected sequence variations in human and Macaca fascicularis beta-defensins 2 on antimicrobial activity.
Antimicrobial agents and chemotherapy 2004;48(2):685-8.
2004: Marina Bacac; Anna C G Hotze; Karlijn van der Schilden; Jaap G Haasnoot; Sabrina Pacor; Enzo Alessio; Gianni Sava; Jan Reedijk
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.
Journal of inorganic biochemistry 2004;98(2):402-12.
2002: Sabrina Pacor; Anna Giangaspero; Marina Bacac; Gianni Sava; Alessandro Tossi
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use.
The Journal of antimicrobial chemotherapy 2002;50(3):339-48.
2001: Sabrina Pacor; Marta Vadori; Francesca Vita; Marina Bacac; Maria Rosa Soranzo; Giuliano Zabucchi; Gianni Sava
Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
Anticancer research 2001;21(4A):2523-30.
2000: Sabrina Pacor; Monica Magnarin; ME Carotenuto; Paola Spessotto; Giuliano Zabucchi; Gianni Sava
In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates.
Anticancer research 2000;20(1A):191-6.
1999: Sabrina Pacor; R Gagliardi; E Di Daniel; Marta Vadori; Gianni Sava
In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative.
International journal of molecular medicine 1999;4(4):369-75.
1999: Sabrina Pacor; R Gagliardi; Paola Spessotto; Giuliano Zabucchi; Gianni Sava
Paracrine effects of IL-4 transfection on TS/A adenocarcinoma cells mediate reduced in vivo growth.
Pathology oncology research : POR 1999;5(2):110-6.
1996: Gianni Sava; Alberta Bergamo; I Capozzi; K Clerici; Sabrina Pacor; R Gagliardi; E Giacomello; M Zacchigna; G Di Luca; E Boccu
Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinoma.
Journal of experimental therapeutics & oncology 1996;1(6):342-9.
1996: Sabrina Pacor; E Giacomello; Alberta Bergamo; K Clerici; M Zacchigna; E Boccu; Gianni Sava
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
Anticancer research 1996;16(5A):2559-64.
1996: Sabrina Pacor; E Giacomello; Alberta Bergamo; R Gagliardi; Moreno Cocchietto; Gianni Sava
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme.
Anticancer research 1996;16(1):145-9.
1995: Gianni Sava; Sabrina Pacor; G Dasić; Alberta Bergamo
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas.
Anticancer research 1995;15(5B):1883-8.
1995: Gianni Sava; Sabrina Pacor; Alberta Bergamo; Moreno Cocchietto; Giovanni Mestroni; Enzo Alessio
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
Chemico-biological interactions 1995;95(1-2):109-26.
1995: Sonia Zorzet; Laura Perissin; Valentina Rapozzi; Sabrina Pacor; Tullio Giraldi
Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.
Clinical & experimental metastasis 1995;13(2):97-104.
1994: R Gagliardi; Gianni Sava; Sabrina Pacor; Giovanni Mestroni; Enzo Alessio
Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse.
Clinical & experimental metastasis 1994;12(2):93-100.
1993: F Bregant; Sabrina Pacor; S Ghosh; S K Chattopadhyay; Gianni Sava
Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
Anticancer research 1993;13(4):1011-7.
1992: G Sava; Sabrina Pacor; E Nardon; Aldo Dobrina
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride.
Journal of chemotherapy (Florence, Italy) 1992;4(4):228-34.
1992: Gianni Sava; Sabrina Pacor; Giovanni Mestroni; Enzo Alessio
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties.
Clinical & experimental metastasis 1992;10(4):273-80.
1992: Gianni Sava; Sabrina Pacor; Giovanni Mestroni; Enzo Alessio
Effects of the Ru(III) complexes [mer-RuCl3(DMSO)2Im]degrees and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors.
Anti-cancer drugs 1992;3(1):25-31.
1992: Sabrina Pacor; Gianni Sava; Giovanni Mestroni; Enzo Alessio
Tumor inhibition and effects on host survival time by rutheniumIII and rhodiumIII complexes with dimethylsulphoxide ligands.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;25 Suppl 1():73-4.
1991: Gianni Sava; V Ceschia; Sabrina Pacor; Giuliano Zabucchi
Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
Anticancer research 1991;11(3):1109-13.
1991: Gianni Sava; Sabrina Pacor; F Bregant; V Ceschia
Metal complexes of ruthenium: a potential class of selective anticancer drugs.
Anticancer research 1991;11(3):1103-7.
1991: Sabrina Pacor; Gianni Sava; V Ceschia; F Bregant; Giovanni Mestroni; Enzo Alessio
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
Chemico-biological interactions 1991;78(2):223-34.
1991: Gianni Sava; Sonia Zorzet; Laura Perissin; Sabrina Pacor; L Lassiani; C Nisi; A Varnavas
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
Cancer chemotherapy and pharmacology 1991;27(6):423-8.
1990: Gianni Sava; Sabrina Pacor; F Bregant; V Ceschia; Giovanni Mestroni
Metal complexes of ruthenium: antineoplastic properties and perspectives.
Anti-cancer drugs 1990;1(2):99-108.
1990: F Bregant; V Ceschia; Sabrina Pacor; Gianni Sava
Reduction of MCa mammary carcinoma in mice fed with egg-white lysozyme.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 3():95-6.
1989: Sabrina Pacor; E Luxich; V Ceschia; Gianni Sava; Enzo Alessio; Giovanni Mestroni
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21 Suppl 1():127-8.
1989: Gianni Sava; V Ceschia; Sabrina Pacor; Sonia Zorzet; Laura Perissin
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
Methods and findings in experimental and clinical pharmacology 1989;11(11):683-9.
1989: Gianni Sava; Sabrina Pacor; Sonia Zorzet; Enzo Alessio; Giovanni Mestroni
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in the Lewis lung carcinoma system.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21(5):617-28.
1989: Gianni Sava; V Ceschia; Sabrina Pacor
Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects.
Anticancer research 1989;9(4):1175-80.
1989: Gianni Sava; Sabrina Pacor; V Ceschia; G Zassinovich; Giovanni Mestroni
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
Anticancer research 1989;9(3):787-90.
1989: Gianni Sava; Sabrina Pacor; V Ceschia; G Zassinovich; Giovanni Mestroni
Inhibition of carrageenin paw edema by pyridinalalkylimine rhodium(I) complexes.
Anticancer research 1989;9(3):767-70.
1989: Gianni Sava; A Benetti; V Ceschia; Sabrina Pacor
Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review).
Anticancer research 1989;9(3):583-91.
1989: Gianni Sava; Sonia Zorzet; Sabrina Pacor; Giovanni Mestroni; G Zassinovich
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma.
Cancer chemotherapy and pharmacology 1989;24(5):302-6.